- Home
- BNR vs VNRX Comparison
BNR vs VNRX Comparison
Compare BNR & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- VNRX
- Stock Information
- Founded
- BNR 2014
- VNRX N/A
- Country
- BNR China
- VNRX United States
- Employees
- BNR N/A
- VNRX N/A
- Industry
- BNR Medical Specialities
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BNR Health Care
- VNRX Health Care
- Exchange
- BNR Nasdaq
- VNRX Nasdaq
- Market Cap
- BNR 61.7M
- VNRX 58.6M
- IPO Year
- BNR 2020
- VNRX N/A
- Fundamental
- Price
- BNR $5.66
- VNRX $0.61
- Analyst Decision
- BNR
- VNRX Strong Buy
- Analyst Count
- BNR 0
- VNRX 4
- Target Price
- BNR N/A
- VNRX $4.17
- AVG Volume (30 Days)
- BNR 5.3K
- VNRX 109.7K
- Earning Date
- BNR 03-27-2025
- VNRX 03-24-2025
- Dividend Yield
- BNR N/A
- VNRX N/A
- EPS Growth
- BNR N/A
- VNRX N/A
- EPS
- BNR N/A
- VNRX N/A
- Revenue
- BNR $72,832,704.00
- VNRX $1,285,827.00
- Revenue This Year
- BNR $52.90
- VNRX $71,446.31
- Revenue Next Year
- BNR $48.35
- VNRX N/A
- P/E Ratio
- BNR N/A
- VNRX N/A
- Revenue Growth
- BNR N/A
- VNRX 97.50
- 52 Week Low
- BNR $0.57
- VNRX $0.43
- 52 Week High
- BNR $8.99
- VNRX $1.10
- Technical
- Relative Strength Index (RSI)
- BNR 40.71
- VNRX 50.66
- Support Level
- BNR $4.41
- VNRX $0.55
- Resistance Level
- BNR $6.33
- VNRX $0.63
- Average True Range (ATR)
- BNR 0.54
- VNRX 0.04
- MACD
- BNR -0.16
- VNRX 0.00
- Stochastic Oscillator
- BNR 35.82
- VNRX 55.00
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.